Add-on saxagliptin improves glycemic status among uncontrolled type 2 diabetes mellitus
نویسندگان
چکیده
منابع مشابه
Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes
INTRODUCTION To investigate whether vildagliptin add-on insulin therapy improves glycemic variations in patients with uncontrolled type 2 diabetes (T2D) compared to patients with placebo therapy. METHODS This was a 24-week, single-center, double-blind, placebo-controlled trial. Inadequately controlled T2D patients treated with insulin therapy were recruited between June 2012 and April 2013. T...
متن کاملBrewer's Yeast Improves Glycemic Indices in Type 2 Diabetes Mellitus
BACKGROUND Brewer's yeast may have beneficial effects on insulin receptors because of itsglucose tolerance factor in diabetic patients. This study was conducted to investigate the effects of brewer's yeast supplementation on glycemic indices in patients with type 2 diabetes mellitus. METHODS In a randomized double-blind controlled clinical trial, 84 adults (21 men and 63 women) aged 46.3 ± 6....
متن کاملEffect of Teneligliptin supplementation as add on therapy to Metformin in Uncontrolled type 2 diabetes mellitus
Diabetes mellitus type 2 (DM) is a long term metabolic disorder that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Metformin is first line drug for diabetes mellitus due to its excellent safety and toleralability. Teneligliptin is newly approved drug for DM and having minimal side effects. Teneligliptin can be used either as monotherapy or add on therap...
متن کاملEffects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes
BACKGROUND To investigate whether saxagliptin add-on therapy to continuous subcutaneous insulin infusion (CSII) further improve blood glycemic control than CSII therapy in patients with newly diagnosed type 2 diabetes (T2D). METHODS This was a single-center, randomized, control, open-labeled trial. Newly diagnosed T2D patients were recruited between February 2014 and December 2015. Subjects w...
متن کاملEffect of Bromocriptine Mesylate as Add-On Therapy in Obese Type 2 Diabetes Mellitus Patients
Six months administration of bromocriptine mesylate significantly decreased glycated hemoglobin (HbA1c), fasting blood sugar, postprandial blood sugar, and weight of 22 Indian obese patients with type 2 diabetes mellitus with no serious adverse events. Therefore, the novel mechanism of action, efficacy and acceptable safety profile makes this drug an attractive option for treatment of obese typ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Research in Medical Sciences
سال: 2018
ISSN: 2320-6012,2320-6071
DOI: 10.18203/2320-6012.ijrms20181758